Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-21

Clinical Trial Update: Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome [Phase 2]

View source ↗

Summary

Long-term follow-up results from a Phase 2 study evaluating the safety, efficacy, and tolerability of rotigotine in adolescents with Restless Legs Syndrome were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine (rotigotine)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-09-21